Association between hydrochlorothiazide exposure and skin and lip cancer: a series of populationbased nested case-control studies

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/34087
• EU PAS number:
  EUPAS24154
• Study ID:
  34087
• Official title and acronym:
  Association between hydrochlorothiazide exposure and skin and lip cancer: a series of populationbased nested case-control studies
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  Observational studies to assess the association between hydrochlorothiazide exposure and lip cancer, non-melanoma skin cancer and melanoma skin cancer.
• Study status:
  Finalised

Research institutions and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned: 05/02/2018

Actual: 05/02/2018

Study start date

Planned: 05/02/2018

Actual: 05/02/2018

Date of final study report

Planned: 06/08/2018

Actual: 25/03/2019

Sources of funding

EMA

Study protocol

Initial protocol

EUPAS24154.protocol

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable